Total and free iodothyronine levels of growing Thoroughbred foals: Effects of weaning and gender

The aim of this study was investigate the effect of growing associated with different gender on circulating total and free iodothyronine concentrations during the first 13 mo of age in foals. In addition, we investigated the evolution of circulating concentrations of thyroid hormones during the first 3 d of weaning. Blood was collected from 13 clinically healthy Thoroughbred foals every month. All foals were weaned at the 4 mo and blood samples were taken also at 24, 48 and 72 h after weaning. The results obtained showed growing effects for tri-iodothyronine (T₃), thyroxine (T₄), free tri-iodothyronine (fT₃) and free thyroxine (fT₄) values (P < .001).

Serum T₃ concentrations averaged respectively 2.89 and 0.29 nmol/L at 7 and 9 mo. Serum T₄ concentrations averaged respectively 100.17 and 21.77 nmol/L at 1 and at 10 mo. Serum fT₃ concentrations averaged respectively 6.96 and 1.50 pmol/L at 1 and 4 mo. Serum fT₄ concentrations averaged respectively 31.40 and 4.93 pmol/L at 1 and 9 mo. Significant correlations between T₃, T₄, fT₃ and fT₄ with body weight (BW) and between T₃, T₄ and fT₄ with age were observed.

Weaning effects (P < .001) were shown for T₃ and fT₄ levels. No differences (P > .05) in T₄ and fT₃ levels were observed over the 3-day period. Gender effects (P < .001) were shown for T₃, T₄, fT₃, and fT₄ levels. Significant correlations between T₄ and fT₄ with BW and age were observed in colts and fillies. T₃ concentrations were correlated with age only in colts and fT₃ with BW only in colts. The results obtained seem to lend support to the recognized effects of growing and weaning in modulating the thyroid function of Thoroughbred foals. In fact, significant and differentiated effects of growing and weaning on total and free iodothyronine levels have been demonstrated.     

Perturbed metabolism and hormonal profiles in calves infected with Sarcocystis cruzi

Plasma concentrations of growth hormone (GH), thyroid stimulating hormone (TSH), insulin (IN), thyroxine (T₄), and triiodothyronine (T₃) in addition to metabolic parameters [N balance (NB), urinary 3-methylhistidine (TMH), urinary creatinine (CR), and urinary hydroxyproline (HP)] were measured in 4-mo-old Holstein steers divided equally among groups infected with Sarcocystis (I), noninfected ad libitum fed (C), and noninfected pair fed to I (PF) (7 steers per treatment). Effects of infection on these parameters beyond those attributable to altered dietary intake were determined using orthogonal contrasts (effect of intake, C vs I + PF; effect of infection, PF vs I). NB was higher in C than I and PF (P<.05) and lower in I than PF (P<.02). Hydroxyproline and CR were influenced by intake (P<.05) and HP excretion was reduced in association with infection (P<.05). Reduced intake was associated with lowered mean basal plasma concentrations of GH, IN, T₃ and T₄ (P<.05). Infection further reduced (P<.001) plasma T₃ concentration.

Triiodothyronine and T₄ responses following an intravenous bolus of thyrotropin releasing hormone (TRH) were measured. The magnitude of the responses in I and PF were lower than those observed in C (P<.05). Plasma T₃ responses were further reduced in association with infection (P<.05). Insulin responses to intravenous arginine infusion (ARG) were also low in association with reduced intake. Growth hormone responses to TRH or ARG were affected by the level of feed intake only. These data suggest that hormonal perturbations associated with the insult of infection further compromise metabolism and the direction of nutrient partitioning that would ordinarily be associated with developmental growth in young steers beyond those responses anticipated from solely the reduction of feed intake.     

Effect of progressive cachectic parasitism and growth hormone treatment on hepatic 5'-deiodinase activity in calves

Thyroid status is compromised in a variety of acute and chronic infections. Conversion of thyroxine (T₄) into the metabolically active hormone, triiodothyronine (T₃), is catalyzed by 5′-deiodinase (5′D) mainly in extrathyroidal tissues. The objective of this study was to examine the effect of protozoan parasitic infection (Sarcocystis cruzi) on hepatic 5′D (type I) activity and plasma concentrations of T₃ and T₄ in placebo- or bovine GH (bGH)-injected calves. Holstein bull calves (127.5±2.0 kg BW) were assigned to control (C, ad libitum fed), infected (I, 250,000 S. cruzi sporocysts per os, ad libitum fed), and pair-fed (PF, non-infected, fed to intake of I treatment) groups placebo-injected, and three similar groups injected daily with pituitary-derived bGH (USDA-B-1, 0.1 mg/kg, i.m.) designated as C_GH, I_GH and PF_GH. GH injections were initiated on day 20 post-infection (PI), 3–4 days prior to the onset of clinical signs of the acute phase response (APR), and were continued to day 56 PI at which time calves were euthanized for liver collection. Blood samples were collected on day 0, 28, and 55 PI. Alterations in nutritional intake did not affect type I 5′D in liver. Treatment with bGH increased (P<0.05) 5′D activity in C (24.6%) and PF (25.5%) but not in I calves. Compared to PF calves, infection with S. cruzi reduced 5′D activity 25% (P<0.05) and 47.8% (P<0.01) in placebo- and bGH-injected calves, respectively. Neither nutrition nor bGH treatment significantly affected plasma concentrations of T₄ and T₃ on day 28 and 55 PI. However, plasma thyroid hormones were reduced by infection. On day 28 PI, the average plasma concentrations of T₃ and T₄ were reduced in infected calves (I and I_GH) 36.4% (P<0.01) and 29.4% (P<0.05), respectively, compared to pair-fed calves (PF and PF_GH). On day 55 PI, plasma T₃ still remained lower (23.7%, P<0.01 versus PF) in infected calves while plasma T₄ returned to control values. The data suggest that parasitic infection in growing calves inhibits both thyroidal secretion and extrathyroidal T₄ to T₃ conversion during the APR. After recovery from the APR, thyroidal secretion returns to normal but basal and bGH-stimulated generation of T₃ in liver remains impaired.     

Effects of dietary T3 on growth parameters and hormone levels in normal and sex-linked dwarf chickens

Tri-iodothyronine (T₃) has been administered in the diet, from day of hatch until 8 weeks of age, to sex-linked dwarf and normal chicks of both sexes from a brown-egg slow-growing strain. Feed was supplemented with either 0.1 ppm or 0.5 ppm T₃. A significant genotype by treatment interaction was observed on body weight: the effect of T₃ in males was significantly positive for dwarfs and null for normals, the effect in females was null for dwarfs and significantly negative for normals. Feed efficiency was rather decreased by the treatment in both genotypes. Abdominal fatness was decreased in a dose-dependent manner in both genotypes, while rectal temperature was raised in dwarf chicks only. Plasma T₃ was raised to normal levels in dwarfs receiving 0.1 ppm exogenous T₃, while the 0.5 ppm dose yielded hyperthyroid levels. Plasma GH levels were decreased in a dose-dependent manner by the T₃ treatment, the effect being larger in dwarfs. Surprisingly, plasma IGF-I was unchanged in spite of the GH decrease, whatever the genotype or the sex. It was concluded that exogenous T₃ alone can have a stimulatory effect on growth in dwarfs but can not fully restore a normal growth rate. Both T₃ and IGF-I are important for a normal growth and the relationships between T₃ and IGF-I production should be further investigated in order to better understand the physiological modifications due to the sex-linked dwarf gene.     

Dietary fatty acids modulate hormone repsonses in lactating cows: Mechanistic role for 5′-deiodinase activity in tissue

Supplemental dietary fat provides excess fatty acids (FA), which can alter circulating concentrations of several hormones. To test the effects of fatty acid isomer type and possible sites of regulation, we abomasally infused fat mixtures high in cis-C_18:1 FA (iTRS) or no infusion (NI) and performed intravenous arginine (ARG) and intramuscular thyrotropin-releasing hormone (TRH) challenges. The experimental design was a replicated 3 × 3 Latin square. Challenges were conducted on Days 10 (ARG) and 12 (TRH) after initiation of fat infusion on each of three 4-wk experimental periods. Plasma concentrations of IGF-I were lower (P < 0.01) when cows received iCIS or iTRS compared with NI. Plasma insulin concentrations increased with ARG but responses were not affected by FA. Plasma growth hormone (GH) was unchanged after ARG. Peak plasma GH and thyroid-stimulating hormone (TSH) responses to TRH were blunted (P < 0.05 and P < 0.1, respectively), whereas thyroxine (T₄) and triiodothyronine (T3) responses were augmented post-TRH (P < 0.01) when cows received either FA isomer. Prolactin responses to TRH were not different between infusion treatments, although basal plasma concentrations before TRH were higher in cows infused with iTRS (P < 0.05). To focus on fat regulation of the thyroid axis, we tested directly in vitro the ability of fatty acids dissolved with sodium taurocholate to affect Type-I 5'-deiodinase (5'D) activity in bovine liver homogenates. Homogenate 5'D was not affected by C_2:0---C10:0 fatty acids, but decreased linearly (P < 0.01) with increasing concentrations of C_12:0---C_16:0 and C_18:1 isomers. CisC_18:1 decreased 5′D more than the trans-isomer (P < 0.01), the difference was only apparent at concentrations greater than 0.25 mM. The data suggest that various aspects of pituitary hormone regulation are differentially affected by FA composition. Fatty acid infusion may accentuate end organ responses in the thyroid axis and decrease IGF-I in the somatotropic axis. The data also suggest that FA isomer may alter patterns of extrathyroidal generation of thyroid hormones via direct influences on 5′D.     

Effect of daily injections of growth hormone-releasing factor and thyrotropin-releasing hormone on growth and endocrine parameters in chickens

The control of growth is a complex mechanism regulated by several metabolic hormones including growth hormone (GH) and thyroid hormones. In avian species, as well as in mammals, GH secretion is regulated by hypothalamic hypophysiotropic hormones. Since thyrotropin-releasing hormone (TRH) and growth hormone-releasing factor (GRF) are potent GH secretagogues in poultry, we were interested in determining the influence of daily intravenous administration of either peptide or both simultaneously on circulating GH and IGF-I concentrations and whether an improvement in growth rate or efficiency would be obtained.

Male broiler chicks were injected once daily for a period of 21 days with either GRF (10 μg/kg), TRH (1 μg/kg) or both GRF and TRH (10 and 1 μg/kg respectively) between four and seven weeks of age. On the last day of the experiment, following intravenous injection of TRH, GRF or a combination of GRF and TRH, plasma GH levels were significantly (P<.05) increased to a similar extent in control chicks and in those which had received daily peptide injections for the previous 21 days. Circulating GH levels between 10 and 90 min post-injection were significantly (P<.05) greater and more than additive than GH levels in chicks injected with both GRF and TRH when compared to those injected with either peptide alone. Mean plasma T₃ concentrations during that same time period were significantly elevated (P<.05) above saline-injected control chick levels in birds treated with TRH or GRF and TRH respectively, regardless of whether the chicks had received peptide injections for the previous 21 days. There was no evidence of pituitary refractoriness to chronic administration of either TRH or GRF injection in terms of growth or thyroid hormone secretion.

Despite the large elevation in GH concentration each day, growth rate, feed efficiency and circulating IGF-I concentrations were not enhanced. Thus the quantity or secretory pattern of GH secretion induced by TRH or GRF administration was not sufficient to increase plasma IGF-I concentration or growth.     

Relationships between the thyroid and somatotropic axes in steers I: Effects of propylthiouracil-induced hypothyroidism on growth hormone, thyroid stimulating hormone and insulin-like growth factor I

The effects of propylthiouracil (PTU)-induced thyroid hormone imbalance on GH, TSH and IGF-I status in cattle were examined. In the first study, four crossbred steers (avg wt 350 kg) were fed a diet dressed with PTU (0, 1, 2 or 4 mg/kg/d BW) in a Latin square design with four 35-d periods. On day 29 in each period, steers were challenged with an intrajugular bolus of thyrotropin releasing hormone (TRH, 1.0 μg/kg). Blood samples were obtained to assess the change in plasma GH and TSH as affected by PTU. Plasma IGF-I was measured from blood samples obtained before and after (every 6 hr for 24 hr) intramuscular injection of bovine GH (0.1 mg/kg, day 31). Doses of 1 and 2 mg/kg PTU increased plasma T₄ (P<.01). At 4 mg/kg, PTU depressed T₄ concentrations to 30% of control (P<.01). Plasma T₃ linearly decreased with increasing doses of PTU (P<.01). Plasma TSH increased when PTU was fed at 4 mg/kg (P<.05) while the TSH response to TRH declined with increasing PTU (P<.02). Neither basal nor TRH-stimulated plasma concentration of GH was affected by PTU; the IGF-I response to GH tended to increase at the 1 and 2 mg/kg PTU (P<.01). In a second study 24 crossbred steers were fed PTU (1.5 mg/kg) for 119 d in a 2 × 2 factorial design with implantation of the steroid growth effector, Synovex-S (200 mg progesterone + 20 mg estradiol), as the other main effect. Basal plasma GH and IGF-I were not affected by PTU treatment. Synovex increased plasma concentration (P<.01) of IGF-I without an effect on plasma GH. The data suggest that mild changes in thyroid status associated with PTU affects regulation of T₃, T₄ and TSH more than GH or IGF-I in steers.     

Dose effect of human growth hormone-releasing factor and thyrotropin-releasing factor on hormone concentrations in lactating dairy cows

Two experiments were conducted to study the effects of growth hormone-releasing factor (GRF) and thyrotropin-releasing factor (TRF) administration on hormone concentrations in dairy cows. In the first trial, 12 cows were used on 5 consecutive days to determine the effect of four sc doses of GRF (0, 1.1, 3.3 and 10 μg•kg⁻¹ BW) and three sc doses of TRF (0, 1.1 and 3.3 μg•kg⁻¹ BW) combined in a factorial arrangement. GRF and TRF acted in synergy (P = .02) on serum growth hormone (GH) concentration even at the lowest dose tested and GH response to the two releasing factors was higher than the maximal response observed with each factor alone. TRF increased (P<.01) prolactin (Prl), thyrotropin (TSH), triiodothyronine (T₃) and thyroxine (T₄) concentrations similarly at the 1.1 and 3.3 μg•kg⁻¹ doses and GRF did not interact (P>.40) with TRF on the release of these hormones. In the second trial, the effect of GRF (3.3 μg•kg⁻¹ BW, sc) and TRF (1.1 μg•kg⁻¹ BW, sc) was tested at three stages (18, 72 and 210 days) of lactation on serum Prl and TSH concentrations. Eighteen cows (n = 6 per stage of lactation) were used in two replicates of a 3 × 3 latin square. The TRF and GRF-TRF treatments were equipotent (P>.05) in increasing Prl and TSH concentrations. Prl and TSH responses were similar (P>.40) throughout lactation. In summary, GRF at doses ranging from 1.1 to 10.0 μg•kg⁻¹ and TRF at doses ranging from 1.1 to 3.3 μg•kg⁻¹ act in synergy on GH release and do not interact on Prl, TSH, T₃ and T₄ concentrations in dairy cows. Furthermore, Prl and TSH response to TRF are not affected by stage of lactation.     

Hormonal changes following an acute stress in control and somatostatin-immunized pigs

Sixteen Yorkshire pigs (49 ± 2 kg BW at 17 weeks) were immunized against somatostatin (SRIF; 4 males, 4 females) or its conjugated protein, bovine serum albumin (BSA; controls; 4 males, 4 females). Immunizations were done at 10, 12 and 14 weeks of age. Jugular vein cannulae were surgically inserted at 17 weeks of age. Five d later, half of each sex from the control and SRIF-immunized groups were stressed. The other half were subjected to the same stress 48 hr later. On both days, remaining animals were used as unstressed controls. The stress consisted of 5 min of snare restraint. Blood samples were collected from all pigs on both days at −20, −15, −10, −5, 0 (beginning of stress), 2, 6, 10, 15, 20, 30, 40, 60, 90, 120, 150, 180 and 240 min. Samples were radioimmunoassayed for cortisol, growth hormone (GH), prolactin (Prl), insulin, triiodothyronine (T₃), thyroxine (T₄) and insulin-like growth factor I (IGF-I). Mean antibody titers against SRIF (1:150 dilution) at 15 weeks were 0.49 ± .09% and 54.5 ± 4.9% for control and SRIF immunized pigs, respectively. Gender and immunization against SRIF had no effect on any of the variables measured (P>0.05), except for T₃ levels which were greater in females than in males (P<0.05). The stress by time of sampling interaction was significant (P<0.01) for all hormones measured. Cortisol values almost tripled within 15 min of stress, reaching concentrations above 100 ng/mL. Maximal increases were seen at 2 min for T₄ (14%), at 6 min for T₃ (36%), at 15 min for Prl (46%) and at 10 min for insulin (141%). An increase of 129% in GH concentration was present at 20 min in stressed pigs; however, an increase of 97% was also seen at 120 min in control pigs. Concentrations of IGF-I decreased (21%) by 60 min in the stressed pigs and remained depressed for up to 150 min. Stress associated with snare restraint, therefore, induces major changes in the concentrations of a series of hormones in growing pigs. On the other hand, immunization against SRIF did not alter any of the hormonal profiles measured. Since snare restraint is widely used to handle pigs during jugular puncture, any study of hormonal secretion in this species should be carried out under carefully controlled conditions in terms of blood sampling technique.     

Effects of cimaterol administration on plasma concentrations of various hormones and metabolites in friesian steers

The aim of the experiment was to determine the acute and chronic effects of the β-agonist, cimaterol, on plasma hormone and metabolite concentrations in steers. Twelve Friesian steers (liveweight = 488 ± 3 kg) were randomly assigned to receive either 0 (control; n=6) or .09 mg cimaterol/kg body weight/day (treated; n=6). Steers were fed grass silage ad libitum. Cimaterol, dissolved in 140 ml of acidified distilled water (pH 4.2), was administered orally at 1400 hr each d. After 13 d of treatment with cimaterol or vehicle (days 1 to 13), all animals were treated with vehicle for a further 7 d (days 14 to 20). On days 1, 13 and 20, blood samples were collected at 20 min-intervals for 4 hr before and 8 hr after cimaterol or vehicle dosing. All samples were assayed for growth hormone (GH) and insulin, while samples taken at −4, −2, 0, +2, +4, +6 and +8 hr relative to dosing were assayed for thyroxine (T₄), triiodothyronine (T₃), cortisol, urea, glucose and non-esterified fatty acids (NEFA). Samples taken at −3 and +3 hr relative to dosing were assayed for IGF-I only. On day 1, cimaterol acutely reduced (P<.05) GH and urea concentrations (7.6 vs 2.9 ± 1.4 ng/ml; and 6.0 vs 4.9 ± 0.45 mmol/l, respectively; mean control vs mean treated ± pooled standard error of difference), and increased (P<.05) NEFA, glucose and insulin concentrations (160 vs 276 ± 22 μmol/l, 4.1 vs 6.2 ± 0.15 mmol/l and 29.9 vs 179.7 ± 13.9 μU/ml, respectively). Plasma IGF-I, T₃, T₄ and cortisol concentrations were not altered by treatment. On day 13, cimaterol increased (P<.05) GH and NEFA concentrations (7.7 vs 14.5 ± 1.4 ng/ml and 202 vs 310 ± 22 mEq/l, respectively) and reduced (P<.05) plasma IGF-I concentrations (1296 vs 776 ± 227 ng/ml). Seven-d withdrawal of cimaterol (day 20) returned hormone and metabolite concentrations to control values. It is concluded that : 1) cimaterol acutely increased insulin, glucose and NEFA and decreased GH and urea concentrations, 2) cimaterol chronically increased GH and NEFA and decreased IGF-I concentrations, and 3) there was no residual effect of cimaterol following a 7-d withdrawal period.     

Relationship of thyroid status to growth hormone and insulin-like growth factor-I (IGF-I) in plasma and IGF-I mRNA in liver and skeletal muscle of cattle

Steers were made hyperthyroid or hypothyroid to study the effects of physiological alterations in thyroid hormone status on plasma growth hormone (GH) profiles, plasma insulin-like growth factor-I (IGF-I) concentrations, and relative abundance of IGF-I mRNA in skeletal muscle and liver. Eighteen yearling crossbred steers (360 to 420 kg) were randomly allotted to hyperthyroid (subcutaneous injection 0.6 μg/kg BW L-thyroxine for 10 d), hypothyroid (oral thiouracil; 0.25% diet plus 12.5 g capsule/d for 17 d), or control (subcutaneous injection 0.9% NaCl) treatment groups. Blood samples were taken for measurement of GH, IGF-I, thyroxine (T₄) and triiodothyronine (T₃) by RIA. Samples of liver and skeletal muscle were taken by biopsy for measurement of IGF-I mRNA by solution hybridization. Steers receiving thiouracil had 57 and 53% (P<.05) lower T₄ and T₃, respectively, than control steers (84.1 and 1.7 ng/ml). The hyperthyroid steers had 228 and 65% greater (P<.05) T₄ and T₃ than control steers. Neither increased nor decreased thyroid status had any significant effects on plasma GH profiles, liver IGF-I mRNA, or plasma concentration of IGF-I. There was no effect of thyroid hormone alteration on skeletal muscle IGF-I mRNA concentrations. The results of this study suggest that short-term changes in thyroid status of cattle had no major impact on the GH-IGF-I axis or skeletal muscle IGF-I mRNA.     

饲粮钙磷水平对伊犁马初乳成分、乳脂脂肪酸组成、产后血液钙磷及激素的影响

旨在研究妊娠后期饲喂不同钙磷水平饲粮对产后伊犁马初乳成分、乳脂脂肪酸组成、血液钙磷及钙磷代谢激素、繁殖及生长代谢激素等生理生化指标的影响，为明确伊犁马在妊娠后期对钙磷的适宜需要量提供参考。本试验选取健康、无亲缘关系、12~13周岁、体重为（380±32）kg、胎次为4~5胎、处于第10妊娠月左右的伊犁马25匹，随机分为5组，每组5个重复。各组饲粮钙饲喂水平分别为36.00、39.00、42.00、45.00和48.00 g·d^-1，磷饲喂水平分别为26.30、28.30、30.30、32.30和34.30 g·d^-1。试验预试期10 d，正试期从第11天至母马分娩后第2天结束。母马分娩后12 h内采集初乳用于测定乳成分和乳脂脂肪酸含量，空腹血液用于测定Ca、P、甲状旁腺素（PTH）、降钙素（CT）、骨钙素（OC）、胎盘催乳素（PL）、垂体催乳素（PRL）、雌酮（E₁）、雌二醇（E₂）、血清孕酮（PROG）、甲状腺素（T₄）、三碘甲状腺原氨酸（T₃）、生长激素（GH）、胰岛素样生长因子-Ⅰ（IGF-1）等激素浓度。结果表明：1）饲粮钙磷水平对初乳中钙、磷、乳脂率、乳糖率均无显著影响，组间乳蛋白率、总固形物、体细胞数、乳脂中饱和脂肪酸（SFA）和不饱和脂肪酸（UFA）比例存在显著差异（P<0.05）。随着饲粮钙、磷水平的增加，乳磷浓度、乳蛋白率和UFA比例呈显著线性增加（P<0.05），总固形物呈显著二次增加（P<0.05），而乳糖率、SFA及肉豆蔻酸比例呈显著线性降低（P<0.05）。2）饲粮钙磷水平显著影响血液中OC和PROG浓度（P<0.05），随着饲粮钙磷水平的增加，血液中离子钙、CT和OC浓度呈显著的线性降低（P<0.05），而PTH和PROG水平呈显著的线性升高（P<0.05）。饲粮钙、磷水平对PL、PRL、E₁、E₂等生殖激素以及T₃、T₄、GH和IGF-1等生长代谢激素浓度均无显著影响。由此可见，在本试验条件下，饲粮钙磷通过提高初乳中乳蛋白率和总固形物来改变乳脂中饱和脂肪酸含量和不饱和脂肪酸比例影响初乳成分；通过降低血液中OC浓度影响钙磷代谢；通过提高血液中PROG浓度影响繁殖状况。     

Effect of exogenous thyrotropin-releasing hormone (TRH) administration on plasma levels of triiodothyronine (T3), thyroxine (T4) and growth hormone (GH) in chronically catheterized suckling piglets.

The purpose of the present study was to determine experimental conditions to stimulate secretion of thyroid hormones (T₃ and T₄) with thyrotropin-releasing hormone (TRH) injections in suckling piglets during the first weeks of postnatal life. Three consecutive experiments were conducted. Four 10–20 d old piglets were i.m. injected with 0, 20, 100, 500 μg (experiment 1) or 0, 4, 20, 100 μg TRH/kg BW (experiment 2) according to a 4 × 4 latin square design involving different litters in each experiment. Blood samples were taken −15, −1, 15, 30, 45, 60, 90, 120 180 and 300 min after TRH injection in experiment 1, and −.25, −.08, .25, .5, 1, 2, 4, 6, 8, 12, 24, 30, 36, 48, 60 and 72 hr after TRH injection in experiment 2. T₃ and T₄ levels were significantly (P<.01) increased as soon as 30 and 45 min after TRH injection, respectively. Maximal levels of T₃ and T₄ were obtained 2 and 4 hr after the injection of 100 μg TRH. T₃ and T₄ returned to basal levels within 6 and 8 hr post injection, respectively. Plasma pGH levels were significantly (P<.001) increased 15 min after TRH injection in piglets injected with 500 μg. In experiment 3, 100 μg TRH/kg BW were injected i.m. either daily or every other day from .0 to 23 days of age. Results showed that T₄ response to TRH did not decrease after repeated injections. These results indicate that daily i.m. injections of 100 μg TRH/kg BW can be used to increase thyroid hormone levels for at least 13 d in the young suckling piglet.     

Administration of recombinant porcine somatotropin (rpST) changes hormone and metabolic status during early pregnancy

The objective of this study was to examine the effects of somatotropin (ST) on porcine reproductive and metabolic statuses during early pregnancy. Four pregnant crossbred gilts received 6 mg of recombinant porcine somatotropin (rpST) daily from days 10 to 27 after artificial insemination while six pregnant gilts served as controls. Blood samples were taken on days 8, 10, 12, 14, 18, 22, and 27 prior to rpST injections (8:00 h) and subsequently at 9:00, 10:00, 12:00, 14:00, 16:00, 18:00, and 20:00 h. On all remaining days of treatment, samples were taken once daily before injections (8:00 h). The samples were assayed for the metabolic hormones: ST, insulin-like growth factor I (IGF-I), insulin, thyroxine (T₄), triiodothyronine (T₃), and cortisol; for metabolites: free fatty acids (FFA) and glucose; and for the reproductive hormones: luteinizing hormone (LH), progesterone, estradiol-17β, estrone sulfate, and prostaglandin F₂. Delivery of rpST daily induced a 20- to 40-fold increase in plasma ST concentrations. Moreover, repeated administration of rpST resulted in a continuous increase in plasma IGF-I concentration (P<0.001), from 191.0±22.3–340.0±15.3 ng/mL 24 h after initial injection to 591.3±46.8 ng/mL after final injections. Mean serum insulin tended to be greater in rpST-treated gilts. Blood concentrations of T₄ were reduced (P<0.05) from day 14 of gestation in treated gilts while T₃ concentrations remained unchanged. Concentrations of both glucose and FFA were greater (P<0.01) and cortisol concentrations were unchanged in treated gilts. Changes in reproductive steroid hormones were minimally affected. Circulating progesterone (P=0.078), and estradiol-17β (P=0.087) concentrations tended to be lower in treated animals. These data show that treatment of pregnant gilts with rpST during early gestation mainly impacts metabolic rather than reproductive status.     

Response of young broiler chickens to chronic injection of recombinant-derived human insulin-like growth factor-I

The purpose of this study was to determine if exogenous insulin-like growth factor-I (IGF-I) would improve growth rate or body composition of young broiler chickens. Broiler cockerels were given a daily intramuscular (im) injection of sodium acetate buffer (buffer control), 100 or 200 μg recombinant-derived human IGF-I (rhIGF-I) per kg body weight from 11 to 24 days of age. Exogenous IGF-I did not affect the average daily gain, average daily feed consumption, or the gain-to-feed ratio of broiler chickens. Although daily injection of 200 μg/kg of rhIGF-I reduced (P<0.05) body ash content, there was no significant effect of IGF-I treatment on either body fat or protein content. Plasma GH levels were depressed (P<0.05) by chronic treatment with rhIGF-I. In contrast, plasma levels of T₃ and T₄ were not affected by rhIGF-I treatment. The half-life of rhIGF-I in plasma was determined at 25 days of age in naive control or chronically-injected chickens after a single intravenous dose of 50 μg rhIGF-I/kg. We found a single compartment, first-order disappearance pattern of rhIGF-I from chicken plasma. The half-life (t_1/2) of rhIGF-I in plasma was similar (t_1/2 = 32.5 min) for naive controls (injected once) or chronically-treated chickens which had received a daily injection of rhIGF-I (100 or 200 μg/kg) for 14 d. These data indicate that daily injection of IGF-I cannot be used to enhance growth performance or body composition of broiler chickens when given during the early growth period. The depression of plasma GH levels in rhIGF-I-injected chickens supports a negative-feedback role of IGF-I on pituitary GH secretion.     

Acute effects of hypophysectomy and administration of pancreatic and thyroid hormones on circulating concentrations of somatomedin-C in young chickens: Relationship between growth hormone and somatomedin-C

The short-term control of plasma concentrations of somatomedin C (SmC) in young chicks was examined by either surgical removal of the pituitary gland or by the administration of hormones which affect plasma concentrations of growth hormone (GH). As expected, removal of the source of GH by hypophysectomy reduced plasma concentration of GH, these being suppressed by 95.7% within 1 hour. Hypophysectomy was rapidly followed by reductions in the plasma concentration of SmC. For instance, plasma concentrations of SmC were decreased to 53% of pretreatment one hour following hypophysectomy. This suggests both that SmC has a short half life and that the release of SmC into the circulation is tightly coupled to the presence of pituitary hormone(s), presumably including GH. Sham surgery also decreased plasma concentrations of GH but were without effect on plasma concentrations of SmC. The short term control of plasma concentrations of SmC was also examined by the acute administration of hormones, which affect GH secretion in vivo. Injections of thyroxine or triiodothyronine decreased the plasma concentration of GH but were without effect on the plasma concentration of SmC. On the other hand, the administration of either glucagon or insulin decreased the plasma concentration of both GH and SmC. The present data suggest that plasma concentrations of SmC do not simply reflect the GH status in young chickens.     

PEG胁迫下紫花苜蓿幼苗内源激素对NO的响应

以紫花苜蓿幼苗为材料,采用聚乙二醇(PEG-6000)为渗透调节物质模拟干旱胁迫,通过外源喷施NO释放剂硝普钠(SNP)和清除剂(cPTIO),用液相色谱/质谱联用(LC/MS)法分析研究PEG胁迫下紫花苜蓿幼苗叶片和根系中4种内源激素脱落酸(ABA)、生长素(IAA)、水杨酸(SA)和赤霉素(GA3)对NO的响应.结...     

Extrathyroidal thyroxine-5′-monodeiodinase activity in cattle

The monodeiodination of thyroxine (T₄) to triiodothyronine (T₃) was studied in vitro using liver, kidney, and muscle obtained from two-year old Angus and Hereford steers. Tissues were homogenized in .1 M phosphate buffer-.25 M sucrose - 5 mM EDTA, pH 7.5, and centrifuged at 2000 × g for 30 min. Supernatants were incubated with T4 (1.3 μM) at 37 C and T₃ generated was measured by radioimmunoassay of an ethanol extract of the incubation mixture. The T₄ to T₃ conversion in Angus liver homogenate was dependent upon pH, temperature, duration of incubation (5–120 min), homogenate (.025–.20 g-eq tissue/ml), and substrate concentration (.32–6.43 μM T₄). The apparent K_m and V_max of the conversion were .64 μM T₄ and 1.87 ng T₃ generated/hr/mg protein, respectively. Mean T₄ to T₃ conversion in Angus liver and kidney was 1.37 and .22 ng T₃/hr/mg protein. The presence of 2 mM dithiothreitol (DTT), a sulfhydryl protective agent, significantly increased T₃ generation in liver and kidney (5.12 and 4.58 ng/hr/mg protein) and also revealed activity in muscle (05 ng/hr/mg protein). In liver and kidney from Hereford steers conversion activity was 2.89 and .48 in absence and 10.91 and 5.38 ng T₃/hr/mg protein in presence of DTT, respectively. These results demonstrate the presence of a very active enzymatic system responsible for the peripheral 5′-monodeiodination of T₄ to T₃ in cattle.     

体外产气法评价生薯条加工副产品-稻草混贮与全株玉米青贮组合效应的研究

旨在探究生薯条加工副产品-稻草混贮（以下简称“薯稻混贮”）与全株玉米青贮间的组合效应。“薯稻混贮”是按照1∶2混合（混贮后的干物质含量为35%）、添加青贮添加剂、用搅拌机混匀、打捆裹包机裹包、发酵60 d制成。根据“薯稻混贮”与全株玉米青贮的不同比例分为7个组合，分别为T₀组（0∶100）、T₂₀组（20∶80）、T₄₀组（40∶60）、T₅₀组（50∶50）、T₆₀组（60∶40）、T₈₀组（80∶20）、T₁₀₀组（100∶0），每个组合3个重复。通过体外产气法，测定各组合发酵48 h干物质降解率（DMD）、pH、氨态氮（NH₃-N）浓度、微生物蛋白（MCP）产量以及挥发性脂肪酸（VFA）浓度等指标，测定各组合在发酵2、4、6、8、10、12、24、36和48 h的产气量（GP）。并计算每个单项组合效应指数（SFAEI）及综合效应指数（MFAEI）。结果表明：1）GP和DMD随“薯稻混贮”比例增加显著或极显著降低（P<0.05或P<0.01）。SFAEI中T₅₀和T₈₀组的GP和DMD最低，GP和DMD最高值均出现在T₂₀组。2）不同组合发酵后的pH值为6.46~6.59，其中T₈₀组pH最高，显著或极显著高于除T₁₀₀组外的其他组别（P<0.05或P<0.01），SFAEI在T₈₀组最高。3）各组合间NH₃-N浓度、MCP产量无显著差异（P>0.05），但均以T₄₀组最高，而SFAEI分别以T₄₀和T₈₀组最高。4）乙酸、丙酸、戊酸和TVFA浓度均以T₀组最高，T₁₀₀组最低，且两组间差异极显著（P<0.01）；丁酸也以T₀组浓度最高，但以T₈₀组浓度最低。SFAEI指标中，乙、丙、丁酸分别以T₈₀、T₂₀和T₆₀组最高。通过MFAEI指数评定得出，两种饲料组合均产生正组合效应，其中T₄₀组（40∶60）最优，其次是T₅₀组（50∶50）。     

The influence of methimazole on the thyrotrophic and peripheral activity of thyrotrophin and thyrotrophin-releasing hormone in the chick embryo and growing chicken

Plasma concentrations of thyroxine (T₄) and triiodothyronine (T₃) were profoundly depressed both in chick embryos and growing chickens after methimazole (MMI) treatment. There was no response of T₄ and T₃ levels to TRH or TSH injections in the MMI group, either in embryos or growing chickens.

Peroxidase activity measured in the thyroid gland was significantly higher in embryos and growing chickens treated with MMI. However, neither TRH nor TSH affected this activity 2 hr after injection in either control or the MMI-treated group.

Hepatic 5′-monodeiodinase activity was significantly stimulated in the MMI-treated groups of embryos and growing chickens but only when additional sulphydryl groups (DTT) were provided. In embryos, monodeiodination activity 2 hr after TSH injection was not significantly different from control values for either DTT-stimulated or unstimulated conditions within the control and MMI-infused groups. However, in both control and MMI-treated embryos monodeiodination activity significantly increased 2 hr after TRH injection. In the growing chickens, monodeiodination activity 2 hr after TRH or TSH injection was not significantly different from control values in either stimulated or unstimulated conditions of each group.